Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Tennessee for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Tennessee only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Tennessee (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Kurt Tauer (NPI 1053340802)

Field	Value
Entity Type	Individual
Organization	Kurt Tauer
Address	7945 Wolf River Blvd
City	Germantown
State	TN
ZIP	38138
Taxonomy	Medical Oncology Physician
NPI Enumerated	July 2, 2006

Payer Source	Total Paid
Medicare	$3.9M
Medicaid	$0

Key Findings

This provider’s Medicare billing is highly concentrated: total Medicare revenue is $3.9M and the precomputed top 3 codes account for 58.9% of this provider's total Medicare revenue. J9271 is the single largest driver with $1.4M in revenue (39.3% of the provider’s Medicare revenue), followed by J9144 at $383K (10.4%) and J9299 at $339K (9.2%), indicating reliance on a small set of high‑volume infused oncology drugs.

The CPT/HCPCS mix points to an infusion-based medical oncology practice focused on immunotherapy and monoclonal antibody treatments: high-revenue drugs include pembrolizumab (J9271), daratumumab (J9144), and nivolumab (J9299). The roster also includes proteasome inhibitors and supportive agents (e.g., J9047, J9264, J2506), plus frequent lab panels and chemotherapy administration codes, consistent with a clinic that manages both systemic cancer therapy and the associated monitoring bundled into outpatient visits.

Competitive standing varies by agent: the provider ranks #78 of 1841 for J9271 (96th percentile) and is described as “notably above typical national volume” for that code, signaling national-level scale for pembrolizumab administration. By contrast, J9144 (rank #211 of 615, 66th percentile) and J9299 (rank #253 of 505, 50th percentile) are in the mid-range of national peers, so the provider is dominant for some agents but more typical for others.

Several codes show statistically extreme or notable outlier behavior for non-drug services: 99214 generated $144.2K from 1.7K claims and ranks #2663 of 479517 (99th percentile; extreme outlier), and M0010 generated $36.6K from 515 claims and ranks #4 of 544 (99th percentile; extreme outlier). These patterns indicate unusually high office-visit volume and exceptional participation in the Enhancing Oncology Model monthly enhanced services relative to national peers, suggesting a practice structured around frequent clinician encounters and formal oncology care management.

The provider appears among a very small national set for certain newer or specialized agents: J9358 (fam-trastuzumab deruxtecan-nxki) shows $164K revenue and ranks #4 of 6 providers nationally (40th percentile), which places this clinician in a narrow group administering that agent. Conversely, some immunotherapies such as durvalumab (J9173) rank low (#50 of 53, 6th percentile), reflecting selective use across different cancer biologics rather than uniformly high volume across all agents.

Supportive care and monitoring activity is prominent: routine labs and panels are frequent relative to peers (85025: 2.9K claims, $23.4K, rank #604 of 32833, 98th percentile; 80048: 2.6K claims, $20.8K, rank #227 of 14725, 98th percentile; 80076: 2.5K claims, $20.1K, rank #77 of 3400, 98th percentile). These high-percentile lab-ordering ranks are consistent with an infusion center that orders baseline and interval labs regularly to support complex systemic therapies.

This provider is effectively single‑payer with respect to public programs: Medicare revenue is $3.9M and there is no Medicaid billing on file, so analyses of payer mix should treat the practice as highly exposed to Medicare policy and reimbursement trends. The absence of Medicaid activity also means state-level Medicaid comparators are not applicable for competitive benchmarking.

The clinician’s NPI was enumerated on 2006-07-02 (~20 years ago), indicating long tenure in the Medicare program. The sustained, high-volume Medicare billing profile combined with long enumeration suggests an established regional practice in Germantown, TN with stable engagement in oncology infusion services and programmatic models like EOM.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

102 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	33,600	$40	$1.4M
J9144	Injection, daratumumab, 10 mg and hyaluronidase‑fihj	10,080	$40	$383K
J9299	Injection, nivolumab, 1 mg	14,740	$20	$339K
J9358	Injection, fam-trastuzumab deruxtecan-nxki, 1 mg	8,200	$20	$164K
J0897	Injection, denosumab, 1 mg	8,700	$20	$156.6K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	1,660	$90	$144.2K
J9047	Injection, carfilzomib, 1 mg	3,970	$40	$142.9K
J9173	Injection, durvalumab, 10 mg	1,830	$60	$113.5K
J1930	Injection, lanreotide, 1 mg	2,520	$40	$108.4K
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	2,680	$40	$93.8K

Showing 1–10 of 102

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 102 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Tennessee Distribution

Kurt Tauer — 5 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Tennessee

Full comparison — all codes billed, vs. state median

102 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	4	50	17,400	$40	$776.1K
J9299	14	20	21,010	$20	$487.5K
J9144	11	20	10,080	$40	$466.3K
J9173	5	10	3,720	$60	$211.7K
J1569	18	30	3,030	$40	$175.2K
J1930	3	10	2,880	$40	$162K
J9358	2	10	7,850	$20	$156.7K
J9047	2	10	3,090	$40	$117.8K
J2353	4	10	650	$150	$106.3K
J1449	6	10	3,630	$30	$98.6K

Showing 1–10 of 102

Related Providers

Other providers that share a Tax Identification Number (TIN) with Kurt Tauer, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Shelby County Health Care Corporation	TN	General Acute Care Hospital	$0	$56.1M
The West Clinic P.C.	TN	Specialist	$0	$16M
David Portnoy	TN	Hematology & Oncology Physician	$6.5M	$0
Gang Tian	TN	Hematology & Oncology Physician	$3.8M	$0
Jason Chandler	TN	Medical Oncology Physician	$3.8M	$0
Syed Sameer Nasir	TN	Hematology & Oncology Physician	$3.5M	$0
Ramakrishna Battini	TN	Hematology & Oncology Physician	$3.3M	$0
Eric Wiedower	TN	Hematology & Oncology Physician	$2.9M	$0
Bradley Somer	TN	Hematology & Oncology Physician	$2.8M	$0
Robert Johnson	TN	Hematology & Oncology Physician	$2.8M	$0

Nearby Providers

Other providers in the same ZIP code as Kurt Tauer, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Byram Healthcare Centers, Inc.	TN	Durable Medical Equipment & Medical Supplies	$0	$44.3M
Campbell Clinic, PC	TN	Orthopaedic Surgery Physician	$0	$28M
Poplar Avenue Clinic PLLC	TN	Gynecologic Oncology Physician	$0	$9.7M
Diagnostic Ultrasound Consultants	TN	Diagnostic Radiology Physician	$0	$8.5M
Mid-south Imaging & Therapeutics, P.A.	TN	Diagnostic Radiology Physician	$0	$8.2M
Stephen Huddleston	TN	Retina Specialist (Ophthalmology) Physician	$5.7M	$0
Stern Cardiovascular Foundation, Inc	TN	Cardiovascular Disease Physician	$0	$4.7M
G I Diagnostic And Therapeutic Center LLC	TN	Endoscopy Clinic/Center	$4.2M	$8.6K
Memphis Neurology PLLC	TN	Neurology Physician	$0	$3.9M
Raza Hashmi	TN	Rheumatology Physician	$3.9M	$0

Kurt Tauer — Billing Profile & Reimbursement Data

Sign up for Kurt Tauer — Billing Profile & Reimbursement Data policy alerts

Kurt Tauer — Billing Profile & Reimbursement Data

Sign up for Kurt Tauer — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References